drugset / Trial / NCT00031889
Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer
RandomizedFactorialOpen-labelTreatment
Summary
RATIONALE: Androgens can stimulate the growth of prostate cancer cells. Hormone therapy using exemestane plus bicalutamide may fight prostate cancer by reducing the production of androgens. It is not yet known if exemestane is more effective with or without bicalutamide in treating prostate cancer. PURPOSE: Randomized phase II trial to study the effectiveness of exemestane with or without bicalutamide in treating patients who have stage IV prostate cancer that has been previously treated with hormone therapy or surgery.
Timeline
- Start
- 2001-08
- Primary completion
- 2002-06
- Completion
- 2002-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bicalutamide | Other / unclassified | — | Oral |
| Comparator | Exemestane | Small molecule | — | Oral |